Lv31
254 积分 2023-12-24 加入
Evaluating generalization in protein-ligand cofolding methods
9小时前
已关闭
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
11天前
已完结
Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem Cells
11天前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
23天前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
27天前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
29天前
已完结
Solute carrier inhibitors in kidney disease therapy: mechanisms and clinical implications
1个月前
已完结
Taking charge of siRNA delivery
1个月前
已完结
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones
1个月前
已完结
RNAi-based drug design: considerations and future directions
1个月前
已完结
皖公网安备34019202002308
